Praxis Medica
Sign in
Issue image

More articles from Volume 50, Issue 1, 2021

A new scoring system for Covid-19 in patients on hemodialysis: Modified Early Warning score

Analysis of the occurrence, location and treatment of laryngeal carcinoma recurrence

Orthodontic treatment of a disto-occlusion with and favorable growth pattern

Sensory processing disorders in premature infants

Examination of early adaptation of newborns small for gestational age

Analysis of the occurrence, location and treatment of laryngeal carcinoma recurrence

Jugoslav Gašić ,
Jugoslav Gašić
View authors publications

Search this author on:

PubMed | Google Scholar
Rajko Jović Orcid logo ,
Rajko Jović
View authors publications

Search this author on:

PubMed | Google Scholar
Zmajko Vučinić
Zmajko Vučinić
View authors publications

Search this author on:

PubMed | Google Scholar

Published: 01.12.2020.

Volume 50, Issue 1 (2021)

pp. 7-11;

https://doi.org/10.5937/pramed2102007g

Abstract

Introduction: The efficacy of the applied model of laryngeal cancer treatment is measured by recurrence. Recurrence significantly reduces survival and determines the type of subsequent treatment. Objective: To determine the incidence of laryngeal cancer recurrence, the location of recurrence, and the definitive treatment of laryngeal cancer recurrence concerning different types of surgical treatments applied. Results: In the period from 2002 to 2017, 844 subjects with primary operated laryngeal squamous cell carcinoma were analyzed. Recurrence developed in 191/844 (22.6%) subjects. The mean recurrence time is 12.6 months. Supraglottic carcinoma is more likely to recur than glottic carcinoma 35.93% / 17.46%, p = 0.000. In N0 necks the recurrence rate is 14.42% and in N + necks it is 45.91, p = 0.000. In more advanced stages of the disease, the number of recurrence increases, p = 0.000. The most common area of recurrence is the neck with 45%, followed by local recurrence with 25.1%. Recurrence most often occurs in subjects with total laryngectomy and partial pharyngectomy, 50%. The most common development of regional recurrence is in the N3 category and extracapsular spread, 72.7%. The definitive treatment of recurrence usually involves radical neck dissection and total laryngectomy. Subjects with recurrence have a significantly lower three-year overall survival compared to those without recurrence, 47.6% / 92.3%, p = 0.000. Conclusion: Recurrence is expected in every fourth patient in the first 36 months following any type of surgical treatment of laryngeal carcinoma. The efficacy of treatment is directly related to recurrence. Recurrence is more common in more advanced stages of disease, extracapsular spread, and present metastases in the neck. Recurrence significantly reduces the overall survival of patients with laryngeal cancer.

References

1.
Siegel RL, Miller KD, Jemal A. Cancer statistics, 2016. Vol. 66, CA: A Cancer Journal for Clinicians. 2016. p. 7–30.
2.
Ferlito A, Haigentz M, Bradley PJ, Suárez C, Strojan P, Wolf GT, et al. Causes of death of patients with laryngeal cancer. Vol. 271, European Archives of Oto-Rhino-Laryngology. 2014. p. 425–34.
3.
Ambrosch P, Fasel A. Functional organ preservation in laryngeal and hypopharyngeal cancer. In 2011. p. 02.
4.
Hörmann K, Sadick H. Role of surgery in the management of head and neck cancer: a conteporary view of the data in the era of organ preservation. Vol. 2013. 2988. p. 1–7.
5.
Spector GJ, Sessions DG, Lenox J, Newland D, Simpson J, Haughey BH. Management of Stage IV Glottic Carcinoma: Therapeutic Outcomes. Vol. 114, The Laryngoscope. 2004. p. 1438–46.
6.
Spector JG, Sessions DG, Haughey BH, Chao KSC, Simpson J, El Mofty S, et al. Delayed Regional Metastases, Distant Metastases, and Second Primary Malignancies in Squamous Cell Carcinomas of the Larynx and Hypopharynx. Vol. 111, The Laryngoscope. 2001. p. 1079–87.
7.
Coca‐Pelaz A, Rodrigo JP, Suárez C. Clinicopathologic analysis and predictive factors for distant metastases in patients with head and neck squamous cell carcinomas. Vol. 34, Head & Neck. 2012. p. 771–5.
8.
Markou K, Christoforidou A, Karasmanis I, Tsiropoulos G, Triaridis S. Constantinidis I, et all Laryngeal cancer: epidemiological data from Northern Greece and review of the literature Hippokratia. Vol. 17. 2013. p. 313–8.
9.
Peretti G, Piazza C, Cocco D, De Benedetto L, Del Bon F, Redaelli De Zinis LO, et al. Transoral CO2 laser treatment for Tis–T3 glottic cancer: The University of Brescia experience on 595 patients. Vol. 32, Head & Neck. 2010. p. 977–83.
10.
Delides A, Maniadakis M, Stathopoulos E. Probabilities of identifying a micrometastasis in a cervical lymph node from laryngeal cancer. A stereometric approach. Vol. 33. 2013. p. 3213–6.
11.
Xu Y, Fei M, Wang J, Zheng L, Chen Y, Liu Q. Clinical significance of micrometastases in lymph nodes from laryngeal squamous cell carcinoma. Vol. 33, American Journal of Otolaryngology. 2012. p. 402–7.
12.
Mandapathil M, Roessler M, Werner JA, Silver CE, Rinaldo A, Ferlito A. Salvage surgery for head and neck squamous cell carcinoma. Vol. 271, European Archives of Oto-Rhino-Laryngology. 2014. p. 1845–50.
13.
Ferlito A, Robbins KT, Medina JE, Silver CE. Proposal for a rational classification of neck dissections. Vol. 33. 2011. p. 445–50.

Citation

Copyright

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

Article metrics

Google scholar: See link

The statements, opinions and data contained in the journal are solely those of the individual authors and contributors and not of the publisher and the editor(s). We stay neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Most read articles

Indexed by
DOAJ
Google Scholar
ERIHPLUS
MIAR I
Crossref